Director, Corporate Strategy

The role

The Director of Corporate Development will lead enterprise strategy, external partnering, and investor engagement. This person will work with senior leadership to translate scientific, clinical, competitive, and financial information into strategic choices and external narratives.

What you will do

• Support development and refinement of enterprise strategy, strategic priorities, and portfolio plans.
• Lead portfolio and scenario analyses integrating scientific, clinical, and financial data.
• Create decision frameworks for program prioritization, resource allocation, and financing.
• Facilitate cross-functional strategy discussions and translate conclusions into actionable plans.
• Lead market, competitive, pipeline, and financing-environment analyses.
• Synthesize information into recommendations for senior leadership and the Board.
• Develop scenario analyses, valuations, and financial models.
• Develop executive and Board materials.
• Identify, assess, and prioritize licensing, collaboration, and partnership opportunities.
• Develop investor presentations, corporate messaging, and diligence materials.

Required qualifications

• 8+ years of relevant experience in biotechnology or pharmaceutical business development, investor relations, corporate strategy, management consulting, investment banking, or a comparable role.
• Demonstrated experience across at least two of the following areas: business development, investor relations, and corporate or portfolio strategy.
• Strong understanding of biotechnology R&D, clinical development, portfolio strategy, partnering, and the drivers of enterprise value.
• Experience evaluating partnerships or licensing opportunities, including diligence, valuation, financial modeling, and transaction support.
• Exceptional written and verbal communication skills.
• Demonstrated ability to lead cross-functional work and manage multiple high-priority workstreams.
• Bachelor's degree required.

Nice to have

• Advanced degree in business, science, medicine, engineering, or a related field
• Experience working across strategy, business development, or investor relations in an early-stage or clinical-stage biotechnology company
• Experience in CNS, neurodegeneration, Alzheimer's disease, or complex disease areas
• Direct experience supporting licensing transactions, strategic partnerships, private financings, investor meetings, or related external processes
• Experience developing investor narratives and materials for a venture-backed or publicly traded biotechnology company
• Familiarity with human genetics, data-driven drug discovery, and platform-based biotechnology models
• Experience supporting executive teams and Boards through major portfolio, financing, or partnering decisions

Benefits

• healthcare coverage
• annual incentive program
• retirement benefits
• broad range of other benefits

About the company

Vesalius Therapeutics has built a unique AI-enabled platform to identify disease-causing biology. The company has formed a strategic collaboration with GSK in Parkinson’s disease and is pursuing multiple other avenues in neurodegeneration and indications outside the CNS.